Evoke Wealth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,166
Closed -$552K 278
2026
Q1
$552K Buy
1,166
+209
+22% +$105K 0.01% 387
2025
Q4
$447K Sell
957
-68
-7% -$31.6K 0.01% 417
2025
Q3
$437K Buy
1,025
+316
+45% +$122K 0.01% 398
2025
Q2
$272K Buy
+709
New +$255K 0.01% 482
2022
Q4
Sell
-103
Closed -$19K 700
2022
Q3
$19K Hold
103
﹤0.01% 647
2022
Q2
$17K Buy
103
+6
+6% +$1.29K ﹤0.01% 682
2022
Q1
$24K Buy
97
+33
+52% +$8.29K ﹤0.01% 623
2021
Q4
$16K Hold
64
﹤0.01% 713
2021
Q3
$15K Sell
64
-12
-16% -$2.93K ﹤0.01% 681
2021
Q2
$16K Sell
76
-21
-22% -$4.28K ﹤0.01% 682
2021
Q1
$18K Buy
97
+30
+45% +$5.29K ﹤0.01% 602
2020
Q4
$11K Sell
67
-475
-88% -$69.5K ﹤0.01% 574
2020
Q3
$68K Sell
542
-20
-4% -$2.48K 0.01% 324
2020
Q2
$55K Buy
562
+468
+498% +$48.7K 0.01% 341
2020
Q1
$8.4K Sell
94
-47
-33% -$6.08K ﹤0.01% 528
2019
Q4
$20.9K Sell
141
-20
-12% -$2.69K ﹤0.01% 580
2019
Q3
$19.4K Buy
+161
New +$20.8K ﹤0.01% 673

Other funds holding HCA

Evoke Wealth's HCA Position: Q2 2026 in Review

Evoke Wealth sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 1,166 shares — an estimated $552K sold.

Evoke Wealth first reported a position in HCA in Q3 2019 and held it in 17 quarters. The position peaked at $552K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Evoke Wealth reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,166 HCA Healthcare shares in Q2 2026, an estimated $552K.
  • Evoke Wealth first reported a position in HCA Healthcare in Q3 2019 and held it in 17 quarters.
  • Evoke Wealth's HCA Healthcare position peaked at $552K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.